Philips et al. conducted a pilot trial of rosiglitazone therapy in fivepatients with thyroglobulin-positive and radioiodine-negative thyroid cancer, aclinical scenario suggestive of dedifferentiation of the thyroid cancer [94]. Here, TG is linked to thyroid gland carcinoma.